Interventional procedure overview of selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver
Closed for comments This consultation ended on at Request commenting lead permission
Table 1 Abbreviations
Abbreviation | Definition |
|---|---|
CI | Confidence interval |
CTCAE | Common Terminology Criteria for Adverse Events |
ECOG | Eastern Cooperative Oncology Group score |
166Hol | Holmium-166 radioisotope |
IQR | Inter-quartile range |
mNET | Metastatic neuroendocrine tumour |
NET | Neuroendocrine tumour |
OR | Odds ratio |
PRRT | Peptide receptor radionuclide therapy |
RECIST | Response Evaluation Criteria in Solid Tumours |
mRECIST | Modified Response Evaluation Criteria in Solid Tumours |
SF-36 | Short form-36 questionnaire |
SIRT | Selective internal radiation therapy |
SMD | Standardised mean difference |
TACE | Transarterial chemoembolisation |
TAE | Transarterial embolisation |
90Y | Yttrium-90 radioisotope |
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions